All stock lists
Kaiser Aluminum Corp (NASDAQ:KALU)
US · Delayed Price · Currency is USD
Basic Materials · Aluminum
118.10+1.98 (+1.71%)
Market cap
$1.93B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 7, 2006
Website
Insider Score
––Not scored
KALU Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
KALU analyst forecast
KALU analyst consensus
Moderate Buy5 ratings
Buy 3 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
KALU 12-month price target
$146.67+24.2% upsideaverage of 3 firms
$158.00High
$127.00Low
KALU ratings mix, last 12 months
Buy Hold Sell
Best analysts covering KALU
- Wells Fargo100%success rate · +14.4% avg return · 1 call
- JP Morgan100%success rate · +12.5% avg return · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
KALU analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | Buy | $158.00 | +49.8% | Reiterated | 2026-10-27 | |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-10-26 |
| Barclays | Overweight | $155.00 | +44.5% | Reiterated | 2026-10-26 | |
| — | JP Morgan | Neutral | — | — | Upgraded | 2026-10-26 |
| KeyBanc | — | $127.00 | +18.4% | — | 2026-10-26 | |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-10-23 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-10-08 |
| KeyBanc | — | $181.00 | +18.9% | — | 2026-10-08 | |
| — | Wells Fargo | Equal Weight | — | — | Upgraded | 2026-09-18 |
| — | UBS | Buy | — | — | Upgraded | 2026-08-31 |
| — | Wells Fargo | Underweight | — | — | Reiterated | 2026-07-24 |
| — | Wells Fargo | Underweight | — | — | Downgraded | 2026-07-09 |
| — | UBS | Neutral | — | — | Reiterated | 2026-07-08 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2026-04-30 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-04-24 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-04-16 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-02-23 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-02-20 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2026-01-13 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-10-28 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-10-24 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-07-28 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-04-28 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-04-21 |
| — | Wolfe Research | Peer Perform | — | — | Upgraded | 2025-04-11 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-07-12 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-04-19 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-04-10 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-02-23 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-01-11 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2023-07-27 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-06-15 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2023-05-08 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2023-05-01 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-04-21 |
| — | Wolfe Research | Underperform | — | — | Downgraded | 2023-04-12 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2023-02-27 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2023-02-14 |
| — | Wolfe Research | Perform | — | — | Reiterated | 2022-12-15 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2022-02-28 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2021-12-10 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2021-09-10 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2021-04-23 |
| — | Benchmark | Buy | — | — | Upgraded | 2020-12-04 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2020-04-17 |
| — | Benchmark | Hold | — | — | Reiterated | 2020-01-16 |
| — | Goldman Sachs | Neutral | — | — | Upgraded | 2019-08-09 |
| — | Jefferies | Buy | — | — | Upgraded | 2018-10-23 |
| — | Goldman Sachs | Sell | — | — | Downgraded | 2018-08-14 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2018-08-01 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2018-07-25 |
| — | Jefferies | Hold | — | — | Reiterated | 2018-07-16 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2018-06-15 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2018-03-20 |
| — | Deutsche Bank | Hold | — | — | Reiterated | 2018-02-27 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2018-02-23 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2017-11-16 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2017-10-20 |
| — | Deutsche Bank | Hold | — | — | Downgraded | 2017-10-17 |
| — | Cowen & Co. | Market Perform | — | — | Downgraded | 2017-08-07 |
KALU earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-18 | 1.56 | 1.53 | $910.0M | $929.0M |
| 2026-04-22 | 1.96 | 3.74 | $999.9M | $1.11B |
| 2026-07-22 | 2.66 | 5.53 | $1.12B | $1.26B |
| 2026-10-21 | 2.37 | 1.89 | $1.21B | $1.21B |
| 2027-02-17Upcoming | 1.54 | — | $1.14B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.